Search results for “Autoimmune inflammatory bowel disease” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 5,821 patents, we discovered top 449 key players by total patent application. Genentech, Inc., Janssen Pharmaceutica NV, Eli Lilly & Co. are dominant in this area. They take 5.36% of the total patent filing.
California, United States
Patent: 121
Antwerpen, Belgium
Patent: 99
Indiana, United States
Patent: 92
Basel-Stadt, Switzerland
Patent: 91
Queensland, Australia
Patent: 89
DUBLIN, Ireland
Patent: 81
Belgium
Patent: 79
Michigan, United States
Patent: 74
California, United States
Patent: 70
New Jersey, United States
Patent: 69
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 231 patents, we discovered top 42 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, First Wave Bio, Inc., SCOHIA PHARMA, Inc. are active in this area.
STARTUP
France
Patent: 47
STARTUP
Michigan, United States
Patent: 30
STARTUP
Kanagawa-ken, Japan
Patent: 16
STARTUP
Telangana, India
Patent: 14
STARTUP
New York, United States
Patent: 11
STARTUP
Guangdong Sheng, China
Patent: 11
STARTUP
Texas, United States
Patent: 11
STARTUP
Israel
Patent: 9
STARTUP
California, United States
Patent: 7
STARTUP
Herefordshire, United Kingdom
Patent: 5
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 2,554 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Protagonist Therapeutics, Inc., Cedars-Sinai Medical Center, Janssen Biotech take 8.03% of patent filing during this period.
Queensland, Australia
Patent: 74
Cedars-Sinai Medical Center
California, United States
Patent: 67
Belgium
Patent: 64
Antwerpen, Belgium
Patent: 50
California, United States
Patent: 38
Nagano-ken, Japan
Patent: 34
STOCKHOLM, Sweden
Patent: 34
DUBLIN, Ireland
Patent: 34
Massachusetts, United States
Patent: 32
Virginia, United States
Patent: 26
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 2,554 patents in last 5 years, we discover 295 new entrants. Kissei Pharmaceutical Co., Ltd., Landos Biopharma, Inc., Second Genome, Inc. are the most active new entrants in this area.
Nagano-ken, Japan
Patent: 34
Virginia, United States
Patent: 26
California, United States
Patent: 20
France
Patent: 16
STARTUP
Kanagawa-ken, Japan
Patent: 16
Jiangsu Sheng, China
Patent: 15
Massachusetts, United States
Patent: 14
France
Patent: 14
Jiangsu Sheng, China
Patent: 13
Innovo Therapeutics Co. Ltd.
South Korea
Patent: 13
Research Institutions
Order by:
Innovation Intensity
With the analysis among 1,372 patents, we discovered top 226 universities and scientific research institutions by total patent application. President & Fellows of Harvard College, Washington University in St. Louis, Osaka University are dominant in this area. They take 9.18% of the total patent filing.
Massachusetts, United States
Patent: 35
Missouri, United States
Patent: 26
Osaka-fu, Japan
Patent: 24
Zhejiang Sheng, China
Patent: 21
United States
Patent: 20
New York, United States
Patent: 20
Tokyo-to, Japan
Patent: 17
Groningen, Netherlands
Patent: 17
Shanghai Shi, China
Patent: 17
New Hampshire, United States
Patent: 16
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: